Abstract
RNA interference is an essential method for studying genomic functions of single genes by loss-of-function experiments. Short interfering siRNAs are efficiently transfected into cultured cells to enable RISC-mediated mRNA cleavage and inhibition of translation in a sequence-specific manner. RNAi enables knockdown of single genes and screening for specific cellular processes or outcomes. In this chapter, we describe a detailed universal protocol for lipoplex-mediated siRNA transfection for cell cultures and cell lysis for subsequent RNA or protein analysis. The experimental procedure is described for verification of knockdown and includes cell lysis for mRNA or protein quantification. Important aspects for specific gene silencing and potential pitfalls are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–811
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494–498
Pratt AJ, MacRae IJ (2009) The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem 284(27):17897–17901. doi:10.1074/jbc.R900012200
Sharma S, Rao A (2009) RNAi screening: tips and techniques. Nat Immunol 10(8):799–804
Dirin M, Winkler J (2013) Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides. Expert Opin Biol Ther 13(6):875–888. doi:10.1517/14712598.2013.774366
Nair JK, Willoughby JLS, Chan A, Charisse K, Alam MR, Wang Q, Hoekstra M, Kandasamy P, Kel’in AV, Milstein S, Taneja N, O’Shea J, Shaikh S, Zhang L, van der Sluis RJ, Jung ME, Akinc A, Hutabarat R, Kuchimanchi S, Fitzgerald K, Zimmermann T, van Berkel TJC, Maier MA, Rajeev KG, Manoharan M (2014) Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J Am Chem Soc 136(49):16958–16961. doi:10.1021/ja505986a
Lorenzer C, Dirin M, Winkler A-M, Baumann V, Winkler J (2015) Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. J Control Release 203:1–15. doi:10.1016/j.jconrel.2015.02.003
Dirin M, Urban E, Lachmann B, Noe CR, Winkler J (2015) Concise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formation. Future Med Chem 7(13):1657–1673. doi:10.4155/fmc.15.109
Gallas A, Alexander C, Davies MC, Puri S, Allen S (2013) Chemistry and formulations for siRNA therapeutics. Chem Soc Rev 42(20):7983–7997. doi:10.1039/C3CS35520A
Winkler J (2013) Oligonucleotide conjugates for therapeutic applications. Ther Deliv 4(7):791–809. doi:10.4155/tde.13.47
Winkler J (2015) Therapeutic oligonucleotides with polyethylene glycol modifications. Future Med Chem 7(13):1721–1731. doi:10.4155/fmc.15.94
Winkler J (2011) Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides. Ther Deliv 2(7):891–905. doi:10.4155/tde.11.56
Winkler J, Gilbert M, Kocourkova A, Stessl M, Noe C (2008) 2′-O-lysylaminohexyl oligonucleotides: modifications for antisense and siRNA. ChemMedChem 3(1):102–110. doi:10.1002/cmdc.200700169
Winkler J, Saadat K, Diaz-Gavilan M, Urban E, Noe C (2009) Oligonucleotide-polyamine conjugates: influence of length and position of 2′-attached polyamines on duplex stability and antisense effect. Eur J Med Chem 44(2):670–677. doi:10.1016/j.ejmech.2008.05.012
Dirin M, Urban E, Noe CR, Winkler J (2016) Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands. Eur J Med Chem 121:132–142. doi:10.1016/j.ejmech.2016.05.001
Höbel S, Aigner A (2013) Polyethylenimines for siRNA and miRNA delivery in vivo. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5(5):484–501. doi:10.1002/wnan.1228
Gaziova Z, Baumann V, Winkler A-M, Winkler J (2014) Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect. Bioorg Med Chem 22(7):2320–2326. doi:10.1016/j.bmc.2014.02.004
Shokrzadeh N, Winkler A-M, Dirin M, Winkler J (2014) Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents. Bioorg Med Chem Lett 24(24):5758–5761. doi:10.1016/j.bmcl.2014.10.045
Doench J, Petersen C, Sharp P (2003) siRNAs can function as miRNAs. Genes Dev:438–442. doi:10.1101/gad.1064703.et
Baumann V, Winkler J (2014) miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem 6(17):1967–1984. doi:10.4155/fmc.14.116
Stessl M, Marchetti-Deschmann M, Winkler J, Lachmann B, Allmaier G, Noe C (2009) A proteomic study reveals unspecific apoptosis induction and reduction of glycolytic enzymes by the phosphorothioate antisense oligonucleotide oblimersen in human melanoma cells. J Proteome 72(6):1019–1030. doi:10.1016/j.jprot.2009.06.001
Winkler J, Stessl M, Amartey J, Noe C (2010) Off-target effects related to the phosphorothioate modification of nucleic acids. ChemMedChem 5(8):1344–1352. doi:10.1002/cmdc.201000156
Krebs S, Fischaleck M, Blum H (2009) A simple and loss-free method to remove TRIzol contaminations from minute RNA samples. Anal Biochem 387(1):136–138. doi:10.1016/j.ab.2008.12.020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Baumann, V., Lorenzer, C., Thell, M., Winkler, AM., Winkler, J. (2017). RNAi-Mediated Knockdown of Protein Expression. In: Kaufmann, M., Klinger, C., Savelsbergh, A. (eds) Functional Genomics. Methods in Molecular Biology, vol 1654. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7231-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7231-9_26
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7230-2
Online ISBN: 978-1-4939-7231-9
eBook Packages: Springer Protocols